Regulation of Sterol Homeostasis
NCT00018720 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-01-21
Summary
The purpose of this study is to determine how people with high triglycerides metabolize and absorb bile acids, compounds made in the body from cholesterol.
This project has two objectives: A) To define the mechanism of impaired bile acid absorption in hypertriglyceridemia (specifically we will determine if the active or passive component of absorption is abnormal) and B) to determine the contribution of an alternative pathway of bile acid synthesis which begins with 27-hydroxylation of cholesterol. Because 27-hydroxylase is present in endothelial cells as well as liver, this pathway may play a role in removal of cholesterol from incipient atherosclerotic plaque.
Conditions
- Hypertriglyceridemia
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Norman Javitt, M.D.
-
Alan Hofmann, M.D.
-
Loren Zech, M.D.
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1996-04-30
- Completion
- 2000-12-31
Countries
- United States
Study Locations
More Related Trials
-
Regulation of Human Intestinal Bile Acid Transport in Health and Disease
NCT00018681 ·Status: COMPLETED
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
NCT03168555 ·Status: COMPLETED ·Phase: PHASE4
-
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
NCT02871882 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of a Probiotic on Hepatic Steatosis
NCT00099723 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
Bileacid Malabsorption and GLP-1 Secretion
NCT03009916 ·Status: COMPLETED ·Phase: PHASE4
-
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NCT04227678 ·Status: RECRUITING ·Phase: NA
-
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
A Feasibility Trial of OCM Supplements for the Treatment of NAFLD
NCT05720702 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Bile Acids As Determinants of Postprandial Metabolism
NCT06758453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects
NCT05569928 ·Status: UNKNOWN ·Phase: NA
-
Paternally Inherited Phenotypes in Cholestasis
NCT03337074 ·Status: UNKNOWN
-
Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
NCT00465751 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
NCT01865812 ·Status: COMPLETED ·Phase: PHASE2
-
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
NCT01879735 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
NCT01791959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals
NCT06610695 ·Status: ENROLLING_BY_INVITATION
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy
NCT01965054 ·Status: WITHDRAWN ·Phase: NA